Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

view more →

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.

view more →

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

view more →

AtaCor Medical is developing a novel extracardiac pacing system that does not require leads or hardware to be placed inside or onto the heart.

view more →

Providing in-home primary care for seniors with complex conditions, especially those with dementia

view more →

Atsena Therapeutics is a clinical-stage, ophthalmology-focused gene therapy company

view more →

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

view more →

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2.

view more →

Ed-tech platform that pairs high achieving, under-resourced students with mentors to guide them to successful career outcomes

view more →

Their clinical research software accelerates timelines by automating multiple high impact processes.

view more →

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

view more →

(BITT) is a Boston-based biopharmaceutical company developing immune-based approaches for the treatment of cancer and infectious diseases.

view more →

Tech-enabled service designed to make caregiving easier for family caregivers

view more →

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into one single catheter.

view more →

Developing first-in-class approach to activate myeloid cells to kill cancer. 

view more →

Provider of a clinical research platform intended to revolutionize the clinical research industry

view more →

Endogenex is a clinical stage company, founded to improve outcomes for people living with Type 2 Diabetes.

view more →

Developer of biologic and medical device technologies for wound management designed to improve the safety and availability of human blood supply.

view more →

GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable the development of precision cancer drugs.

view more →

GoCheck Kids is the leading digital vision screening platform for children. 

view more →

Gozio promotes loyalty and growth for a health system by creating a system-specific app that enhances the patient experience.

view more →

Huma.ai is a next-generation low code/no code data science solution for the life sciences industry.

view more →

IMMvention is developing novel, first-in-class therapies for treating hemolytic anemias.

view more →

iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

view more →

We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles.

view more →

Operator of a biopharmaceutical agency intended to offer drugs for the treatment of diabetes and other metabolic disorders.

view more →

Perfuse Therapeutics, Inc. is a seed stage biotechnology company focusing on improving retinal perfusion

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke.

view more →

The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.

view more →

Software and logistics solution for physicians allowing them to become independent DME suppliers

view more →

SafeRide’s technology provides end-to-end data transparency while improving patient experience, population health, and program efficiency.

view more →

Platform linking natural compounds and ethnobotanical evidence to generate novel drug candidates

view more →

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

view more →

Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases.

view more →

Developer of novel engineered compounds designed to corneal dystrophies, improve human health and create new therapies using drugs developed with protein engineering.

view more →

Tune strives to develop paradigm-changing cell and gene therapies.

view more →

Provides analytics and software infrastructure to support the operations of social care networks, Medicaid waiver programs, and value-based care organizations

view more →

Sleep management platform built to address sleep conditions from testing through ongoing care via a wearable patch

view more →

Developer of health engagement platform intended to connect families to health resources on the smartphone.

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910